Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Reduced presynaptic dopamine activity in adolescent dorsal striatum.

Matthews M, Bondi C, Torres G, Moghaddam B.

Neuropsychopharmacology. 2013 Jun;38(7):1344-51. doi: 10.1038/npp.2013.32.

2.

Epinephrine administration at birth prevents long-term changes in dopaminergic parameters caused by Cesarean section birth in the rat.

Boksa P, Zhang Y.

Psychopharmacology (Berl). 2008 Oct;200(3):381-91. doi: 10.1007/s00213-008-1213-9.

PMID:
18542929
3.

Acrylamide increases dopamine levels by affecting dopamine transport and metabolism related genes in the striatal dopaminergic system.

Pan X, Guo X, Xiong F, Cheng G, Lu Q, Yan H.

Toxicol Lett. 2015 Jul 2;236(1):60-8. doi: 10.1016/j.toxlet.2015.04.017.

PMID:
25943760
5.

Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.

Hall FS, Itokawa K, Schmitt A, Moessner R, Sora I, Lesch KP, Uhl GR.

Neuropharmacology. 2014 Jan;76 Pt A:146-55. doi: 10.1016/j.neuropharm.2013.07.031.

6.

Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats.

Yu PL, Wu CI, Lee TS, Pan WH, Wang PS, Wang SW.

J Cell Biochem. 2009 Dec 15;108(6):1318-24. doi: 10.1002/jcb.22361.

PMID:
19830701
7.

Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.

Hewett J, Johanson P, Sharma N, Standaert D, Balcioglu A.

J Neurochem. 2010 Apr;113(1):228-35. doi: 10.1111/j.1471-4159.2010.06590.x.

8.
10.

Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum.

Mukda S, Vimolratana O, Govitrapong P.

Neurosci Lett. 2011 Jan 20;488(2):154-7. doi: 10.1016/j.neulet.2010.11.019.

PMID:
21078367
11.
12.

Amphetamine potency varies with dopamine uptake rate across striatal subregions.

Siciliano CA, Calipari ES, Jones SR.

J Neurochem. 2014 Nov;131(3):348-55. doi: 10.1111/jnc.12808.

13.

Are striatal tyrosine hydroxylase interneurons dopaminergic?

Xenias HS, Ibáñez-Sandoval O, Koós T, Tepper JM.

J Neurosci. 2015 Apr 22;35(16):6584-99. doi: 10.1523/JNEUROSCI.0195-15.2015.

14.

Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring.

Naef L, Moquin L, Dal Bo G, Giros B, Gratton A, Walker CD.

Neuroscience. 2011 Mar 10;176:225-36. doi: 10.1016/j.neuroscience.2010.12.037.

PMID:
21187125
15.

The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.

Przegaliński E, Jaworska L, Konarska R, Gołembiowska K.

Neuropeptides. 1991 Jul;19(3):189-95.

PMID:
1680223
16.

Brain Region-Specific Trafficking of the Dopamine Transporter.

Block ER, Nuttle J, Balcita-Pedicino JJ, Caltagarone J, Watkins SC, Sesack SR, Sorkin A.

J Neurosci. 2015 Sep 16;35(37):12845-58. doi: 10.1523/JNEUROSCI.1391-15.2015.

17.

Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.

Tucker KR, Block ER, Levitan ES.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4485-94. doi: 10.1073/pnas.1503766112.

18.

Decreased plasma membrane expression of striatal dopamine transporter in aging.

Salvatore MF, Apparsundaram S, Gerhardt GA.

Neurobiol Aging. 2003 Dec;24(8):1147-54.

PMID:
14643386
19.

Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.

Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, Mosharov EV, McCabe BD, Freyberg R, Wimalasena K, Hsin LW, Sames D, Krantz DE, Katz JL, Sulzer D, Javitch JA.

Nat Commun. 2016 Feb 16;7:10652. doi: 10.1038/ncomms10652.

20.

Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.

Rodríguez VM, Limón-Pacheco JH, Mendoza-Trejo MS, González-Gallardo A, Hernández-Plata I, Giordano M.

Neurotoxicology. 2013 Jan;34:82-94. doi: 10.1016/j.neuro.2012.10.012.

PMID:
23123945

Supplemental Content

Support Center